A blood test that assists in the identification of risk factors for a severe and potentially life-threatening complication of pregnancy is becoming more available in Georgia after a recent United States Food and Drug Administration approval.
The biomarker test screens for signs of severe preeclampsia.
Preeclampsia is a disorder of high blood pressure that typically occurs after the 20th week of pregnancy or after childbirth. The condition affects 5 to 7 percent of all pregnancies, according to the U.S. Centers for Disease Control and Prevention.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
